The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Khuri, F. R., Nemunaitis, J., Ganly, I., Arseneau, J., Tannock, I. F., Romel, L., Gore, M., Ironside, J., MacDougall, R. H., Heise, C., et al. (2000) · Nature Medicine · doi:10.1038/78638 · Cited by 1,101
Self-citationMarkert, J. M., Medlock, M. D., Rabkin, S. D., Gillespie, G. Y., Todo, T., Hunter, W. D., Palmer, C. A., Feigenbaum, F., Tornatore, C., Tufaro, F., et al. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301205 · Cited by 976
Rampling, R., Cruickshank, G., Papanastassiou, V, Nicoll, J., Hadley, D., Brennan, D., Petty, R., MacLean, A., Harland, J., McKie, E., et al. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301184 · Cited by 598
Hu, J. C. C., Coffin, R. S., Davis, C. J., Graham, N. J., Groves, N., Guest, P. J., Harrington, K. J., James, N. D., Love, C. A., McNeish, I., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0759 · Cited by 569
Kirn, D., Martuza, R. L., & Zwiebel, J. (2001) · Nature Medicine · doi:10.1038/89901 · Cited by 502
Self-citationHecht, J. R., Bedford, R. A., Abbruzzese, J. L., Lahoti, S., Reid, T. R., Soetikno, R. M., Kirn, D. H., & Freeman, S. M. (2003) · PubMed · Cited by 494
Self-citationNemunaitis, J., Khuri, F., Ganly, I., Arseneau, J., Posner, M., Vokes, E., Kuhn, J., McCarty, T., Landers, S., Blackburn, A., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.289 · Cited by 471
Self-citationRisks and Benefits of Phase 1 Oncology Trials, 1991 through 2002
Horstmann, E., McCabe, M. S., Grochow, L., Yamamoto, S., Rubinstein, L., Budd, T., Shoemaker, D., Emanuel, E. J., & Grady, C. (2005) · New England Journal of Medicine · doi:10.1056/nejmsa042220 · Cited by 441
Chiocca, E. A., Abbed, K. M., Tatter, S., Louis, D. N., Hochberg, F. H., Barker, F., Kracher, J., Grossman, S. A., Fisher, J. D., Carson, K., et al. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.07.021 · Cited by 436
Ganly, I., Kirn, D. H., Eckhardt, G., Rodriguez, G. I., Soutar, D. S., Otto, R., Robertson, A. G., Park, O., Gulley, M. L., Heise, C. C., et al. (2000) · PubMed · Cited by 432
Self-citationREGRESSION OF BURKITT'S LYMPHOMA IN ASSOCIATION WITH MEASLES INFECTION
Bluming, A., & Ziegler, J. (1971) · The Lancet · doi:10.1016/s0140-6736(71)92086-1 · Cited by 410
Phase I/II Trial of Intravenous NDV-HUJ Oncolytic Virus in Recurrent Glioblastoma Multiforme
Freeman, A. I., Zakay-Rones, Z., Gomori, J. M., Linetsky, E., Rasooly, L., Greenbaum, E., Rozenman-Yair, S., Panet, A., Libson, E., Irving, C. S., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.08.016 · Cited by 407
Nemunaitis, J. J., Ganly, I., Khuri, F. R., Arseneau, J. C., Kuhn, J., McCarty, T. M., Landers, S., Maples, P. B., Romel, L., Randlev, B., et al. (2000) · PubMed · Cited by 404
Self-citationDeWeese, T. L., van der Poel, H. G., Li, S., Mikhak, B., Drew, R., Goemann, M., Hamper, U. M., DeJong, R., Detorie, N. A., Rodríguez, R., et al. (2001) · PubMed · Cited by 385
Pecora, A. L., Rizvi, N., Cohen, G. I., Meropol, N. J., Sterman, D., Marshall, J. L., Goldberg, S., Gross, P., O’Neil, J. D., Groene, W. S., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.042 · Cited by 385
Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma
Mastrangelo, M. J., Maguire, H. C., Eisenlohr, L. C., Laughlin, C. E., Monken, C. E., McCue, P. A., Kovatich, A. J., & Lattime, E. C. (1999) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700066 · Cited by 353
Kirn, D. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301377 · Cited by 349
Self-citationHarrow, S., Papanastassiou, V, Harland, J., Mabbs, R., Petty, R., Fraser, M., Hadley, D., Patterson, J., Brown, S. M., & Rampling, R. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302289 · Cited by 342
Papanastassiou, V, Rampling, R., Fraser, M., Petty, R., Hadley, D., Nicoll, J., Harland, J., Mabbs, R., & Brown, M. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301664 · Cited by 328
Freytag, S. O., Khil, M. S., Stricker, H. J., et al. (2002) · PubMed · Cited by 310
Reid, T. R., Galanis, E., Abbruzzese, J. L., Sze, D., Wein, L. M., Andrews, J., Randlev, B., Heise, C. C., Uprichard, M. J., Hatfield, M. J., et al. (2002) · PubMed · Cited by 309
Self-citationMulvihill, S., Warren, R., Venook, A., Adler, A., Randlev, B., Heise, C., & Kirn, D. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301398 · Cited by 299
Self-citationNemunaitis, J., Cunningham, C., Buchanan, A., Blackburn, A., Edelman, G., Maples, P., Netto, G., Tong, A., Randlev, B., Olson, S., et al. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301424 · Cited by 283
Self-citationFreytag, S. O., Stricker, H. J., Pegg, J., Paielli, D. L., Pradhan, D. G., Peabody, J. O., de Peralta‐Venturina, M., Xia, X., Brown, S., Lü, M., et al. (2003) · PubMed · Cited by 271
Vasey, P. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1562 · Cited by 245
Reid, T., Galanis, E., Abbruzzese, J., Sze, D., Andrews, J., Romel, L., Hatfield, M., Rubin, J., & Kirn, D. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301512 · Cited by 243
Self-citationXia, Z.-J., Chang, J.-H., Zhang, L., et al. (2004) · PubMed · Cited by 241
Small, E. J., Carducci, M. A., Burke, J. M., Rodriguez, R., Fong, L., van Ummersen, L., Yu, D. C., Aimi, J., Ando, D., Working, P., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.02.011 · Cited by 241
Self-citationCRAWFORD, J. (1974) · The Lancet · doi:10.1016/s0140-6736(74)92370-8 · Cited by 239
Treatment of human cancer with mumps virus
Asada, T. (1974) · Cancer · doi:10.1002/1097-0142(197412)34:6<1907::aid-cncr2820340609>3.0.co;2-4 · Cited by 213
MTH-68/H Oncolytic Viral Treatment in Human High-Grade Gliomas
Csatary, L. K., Gosztonyi, G., Szeberenyi, J., Fabian, Z., Liszka, V., Bodey, B., & Csatary, C. M. (2004) · Journal of Neuro-Oncology · doi:10.1023/b:neon.0000021735.85511.05 · Cited by 200
Wein, L. M., Wu, J. T. K., & Kirn, D. H. (2003) · PubMed · Cited by 188
Self-citationIntralesional injection of herpes simplex virus 1716 in metastatic melanoma
MacKie, R. M., Stewart, B., & Brown, S. M. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04048-4 · Cited by 171
Kemeny, N., Brown, K., Covey, A., Kim, T., Bhargava, A., Brody, L., Guilfoyle, B., Haag, N. P., Karrasch, M., Glasschroeder, B., et al. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.1214 · Cited by 171
Phase I–II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas
Galanis, E., Okuno, S. H., Nascimento, A. G., Lewis, B. D., Lee, R. A., Oliveira, A. M., Sloan, J. A., Atherton, P., Edmonson, J. H., Erlichman, C., et al. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302436 · Cited by 170
Self-citationMakower, D., Rozenblit, A. M., Kaufman, H. L., Edelman, M. C., Lane, M. E., Zwiebel, J. A., Haynes, H., & Wadler, S. (2003) · PubMed · Cited by 148
Phase II Trial of Intravenous CI-1042 in Patients With Metastatic Colorectal Cancer
Hamid, O., Varterasian, M. L., Wadler, S., Hecht, J. R., Benson, A. B., Galanis, E., Uprichard, M. J., Omer, C. A., Bycott, P. W., Hackman, R. C., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.114 · Cited by 146
Self-citationClinical trial of E1B-deleted adenovirus (dl1520) gene therapy for hepatocellular carcinoma
Habib, N. A., Salama, H., Median, A. A. E. L. A., et al. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700431 · Cited by 127
Lü, W. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i24.3634 · Cited by 124
E1B-Deleted Adenovirus ( dl 1520) Gene Therapy for Patients with Primary and Secondary Liver Tumors
Habib, N. A., Sarraf, C., Mitry, R. R., et al. (2001) · Human Gene Therapy · doi:10.1089/10430340150218369 · Cited by 117
Attenuated veterinary virus vaccine for the treatment of cancer.
Csatáry, L. K., Eckhardt, S., Bukosza, I., et al. (1993) · PubMed · Cited by 114
Use of Vaccinia Virus in the Treatment of Metastatic Malignant Melanoma
Hunter-Craig, I. D., Newton, K. A., Westbury, G., & Lacey, B. W. (1970) · BMJ · doi:10.1136/bmj.2.5708.512 · Cited by 99
Use of Newcastle Disease Virus Vaccine (MTH-68/H) in a Patient With High-grade Glioblastoma
Csatáry, L. K., & Bakács, T. (1999) · JAMA · doi:10.1001/jama.281.17.1588-a · Cited by 97
Nemunaitis, J. J., Cunningham, C., Tong, A. W., Post, L. E., Netto, G. J., Paulson, A. S., Rich, D., Blackburn, A., Sands, B. E., Gibson, B., et al. (2003) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700585 · Cited by 90
VIRUSES IN THE TREATMENT OF CANCER
Csatáry, L. K. (1971) · The Lancet · doi:10.1016/s0140-6736(71)92788-7 · Cited by 65
Immunotherapy of Malignant Melanoma With Vaccinia Virus
Roenigk, H. H. (1974) · Archives of Dermatology · doi:10.1001/archderm.1974.01630050014003 · Cited by 50
H-1 Virus Viremia in the Human.
Toolan, H. W., Saunders, E. L., Southam, C. M., Moore, A. E., & LEVIN, A. G. (1965) · Experimental Biology and Medicine · doi:10.3181/00379727-119-30278 · Cited by 47
TREATMENT OF PRIMARY MELANOMA BY INTRALESIONAL VACCINIA BEFORE EXCISION
Everall, J. D., Wand, J. S., O’Doherty, C. J., & Dowd, P. M. (1975) · The Lancet · doi:10.1016/s0140-6736(75)90172-5 · Cited by 46
Morley, S. E., MacDonald, G., Kirn, D. H., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0443 · Cited by 39
Self-citation[Safety of an E1B deleted adenovirus administered intratumorally to patients with cancer].
Yuan, Z. Y., Zhang, L., Li, S., et al. (2003) · PubMed · Cited by 23
Cited by
Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
Wicki, A., Witzigmann, D., Balasubramanian, V., & Huwyler, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.030 · Cited by 1,901
Russell, S. J., Peng, K.-W., & Bell, J. C. (2012) · Nature Biotechnology · doi:10.1038/nbt.2287 · Cited by 1,428
Heo, J., Reid, T., Ruo, L., Breitbach, C. J., Rose, S., Bloomston, M., Cho, M., Lim, H. Y., Chung, H. C., Kim, C. W., et al. (2013) · Nature Medicine · doi:10.1038/nm.3089 · Cited by 779
Self-citationLee, C. S., Bishop, E. S., Zhang, R., Yu, X., Farina, E. M., Yan, S., Zhao, C., Zeng, Z., Shu, Y., Wu, X., et al. (2017) · Genes & Diseases · doi:10.1016/j.gendis.2017.04.001 · Cited by 691
“In phase I and II trials, ONYX-015 has demonstrated safety and tolerance when administered via intratumoral, intravascular, or intraperitoneal injection in patients with various advanced cancers.(166,169) Furthermore, available results have since shown ONYX-015 is most effective in conjunction with conventional chemot…”
BackgroundGoing viral with cancer immunotherapy
Lichty, B. D., Breitbach, C. J., Stojdl, D. F., & Bell, J. C. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3770 · Cited by 581
Metadata
- Authors
- Liu, T.-C., Galanis, E., & Kirn, D.
- Venue
- Nature Clinical Practice Oncology
- Published
- 2007-02
- Volume
- 4
- Issue
- 2
- Pages
- 101-117
- ISSN
- 1743-4254 (ISSN-L)
- 1743-4262
- OpenAlex
- W2025822934
- Cited by
- 450
- References
- 50
- FWCI
- 19.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.